Literature DB >> 31503157

Exploring Inflammatory Mediators in Fetal and Maternal Compartments During Human Parturition.

Ramkumar Menon1, Brandie D Taylor.   

Abstract

OBJECTIVE: To examine inflammatory mediators in three fetomaternal biological compartments to inform theory related to the fetal and maternal inflammatory contributions to parturition at term and preterm.
METHODS: We conducted a cross-sectional study of amniotic fluid, cord blood, and maternal plasma from women with singleton pregnancies. Women had one of four conditions: term labor (n=11), term not in labor (n=13), spontaneous preterm birth with intact membranes (preterm birth; n=13), or preterm prelabor rupture of membranes (PROM; n=8). We measured two damage-associated molecular pattern markers (high-mobility group box-1 [HMGB1] and uric acid) and two acute phase response markers (interleukin [IL]-6 and C-reactive protein [CRP]) using enzyme-linked immunosorbent assay. The distribution of each analyte within amniotic fluid, cord blood, and maternal plasma across the four conditions (term not in labor, term labor, preterm birth, and preterm PROM) were calculated. To explore whether there were distributional differences in each analyte across each of the four labor conditions, we used a nonparametric Kruskal-Wallis test. For analytes that differed across groups, we further compared distributions by labor group (term labor vs term not in labor, and preterm PROM vs preterm birth).
RESULTS: Fetal compartments (amniotic fluid and cord blood) showed higher HMGB1 in term labor vs term not in labor and preterm PROM vs preterm birth. Amniotic fluid IL-6, cord blood CRP and cord blood uric acid were higher in term vs term not in labor. Cord blood uric acid was higher in preterm PROM vs preterm birth. Only maternal plasma IL-6 was higher in term labor vs term not in labor.
CONCLUSION: Accumulation of HMGB1 and an overall increase in inflammation observed on the fetal side, but not the maternal side, may be signals of parturition. Understanding fetal-derived proparturition inflammatory signals at term and preterm, especially in preterm PROM, might provide fetal-specific biomarkers and identify underlying mechanisms and targets for interventions to reduce the risk of preterm birth and preterm PROM.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31503157      PMCID: PMC7067539          DOI: 10.1097/AOG.0000000000003470

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  47 in total

Review 1.  The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity.

Authors:  Stacy Beck; Daniel Wojdyla; Lale Say; Ana Pilar Betran; Mario Merialdi; Jennifer Harris Requejo; Craig Rubens; Ramkumar Menon; Paul F A Van Look
Journal:  Bull World Health Organ       Date:  2009-09-25       Impact factor: 9.408

Review 2.  More than obvious: better methods for interpreting nondetect data.

Authors:  Dennis R Helsel
Journal:  Environ Sci Technol       Date:  2005-10-15       Impact factor: 9.028

Review 3.  Inflammatory reaction and implantation: the new entries PTX3 and D6.

Authors:  C Garlanda; V Maina; Y Martinez de la Torre; M Nebuloni; M Locati
Journal:  Placenta       Date:  2008-08-03       Impact factor: 3.481

4.  Technical note: Application of the Box-Cox data transformation to animal science experiments.

Authors:  M R Peltier; C J Wilcox; D C Sharp
Journal:  J Anim Sci       Date:  1998-03       Impact factor: 3.159

5.  Uric acid induces trophoblast IL-1β production via the inflammasome: implications for the pathogenesis of preeclampsia.

Authors:  Melissa J Mulla; Kledia Myrtolli; Julie Potter; Crina Boeras; Paula B Kavathas; Anna K Sfakianaki; Serkelem Tadesse; Errol R Norwitz; Seth Guller; Vikki M Abrahams
Journal:  Am J Reprod Immunol       Date:  2011-06       Impact factor: 3.886

Review 6.  Fetal membrane architecture, aging and inflammation in pregnancy and parturition.

Authors:  Ramkumar Menon; Lauren S Richardson; Martha Lappas
Journal:  Placenta       Date:  2018-11-10       Impact factor: 3.481

7.  Overadjustment bias and unnecessary adjustment in epidemiologic studies.

Authors:  Enrique F Schisterman; Stephen R Cole; Robert W Platt
Journal:  Epidemiology       Date:  2009-07       Impact factor: 4.822

8.  Oxidative stress damage-associated molecular signaling pathways differentiate spontaneous preterm birth and preterm premature rupture of the membranes.

Authors:  Eryn H Dutta; Faranak Behnia; Istvan Boldogh; George R Saade; Brandie D Taylor; Marian Kacerovský; Ramkumar Menon
Journal:  Mol Hum Reprod       Date:  2015-12-21       Impact factor: 4.025

9.  Placental membrane aging and HMGB1 signaling associated with human parturition.

Authors:  Ramkumar Menon; Faranak Behnia; Jossimara Polettini; George R Saade; Judith Campisi; Michael Velarde
Journal:  Aging (Albany NY)       Date:  2016-02       Impact factor: 5.682

Review 10.  Programmed Fetal Membrane Senescence and Exosome-Mediated Signaling: A Mechanism Associated With Timing of Human Parturition.

Authors:  Ramkumar Menon; Sam Mesiano; Robert N Taylor
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-17       Impact factor: 5.555

View more
  16 in total

Review 1.  Fetal inflammatory response at the fetomaternal interface: A requirement for labor at term and preterm.

Authors:  Ramkumar Menon
Journal:  Immunol Rev       Date:  2022-03-14       Impact factor: 10.983

2.  Modeling ascending infection with a feto-maternal interface organ-on-chip.

Authors:  Lauren S Richardson; Sungjin Kim; Arum Han; Ramkumar Menon
Journal:  Lab Chip       Date:  2020-11-24       Impact factor: 6.799

3.  Extracellular vesicle mediated feto-maternal HMGB1 signaling induces preterm birth.

Authors:  Enkhtuya Radnaa; Lauren S Richardson; Samantha Sheller-Miller; Tuvshintugs Baljinnyam; Mariana de Castro Silva; Ananth Kumar Kammala; Rheanna Urrabaz-Garza; Talar Kechichian; Sungjin Kim; Arum Han; Ramkumar Menon
Journal:  Lab Chip       Date:  2021-05-18       Impact factor: 6.799

4.  The protective role of serum uric acid against premature membrane rupture in gestational diabetes: a cross-sectional study.

Authors:  Meixiang Guo; Jun Lu; Xuemei Yu; Xiaowen Hu; Wenjing Hou; Shuguang Pang
Journal:  BMC Endocr Disord       Date:  2021-05-06       Impact factor: 2.763

5.  Term Neonatal Complications During the Second Localized COVID-19 Lockdown and Prolonged Premature Rupture of Membranes at Home Among Nulliparas With Reference Interval for Maternal C-Reactive Protein: A Retrospective Cohort Study.

Authors:  Yang Geng; Weihua Zhao; Wenlan Liu; Jie Tang; Hui Zhang; Weilin Ke; Runsi Yao; Ji Xu; Qing Lin; Yun Li; Jianlin Huang
Journal:  Front Pediatr       Date:  2022-04-08       Impact factor: 3.569

Review 6.  Role of Decidual Natural Killer Cells in Human Pregnancy and Related Pregnancy Complications.

Authors:  Xiuhong Zhang; Haiming Wei
Journal:  Front Immunol       Date:  2021-08-26       Impact factor: 7.561

Review 7.  The role of cellular senescence in female reproductive aging and the potential for senotherapeutic interventions.

Authors:  Laura Secomandi; Michela Borghesan; Michael Velarde; Marco Demaria
Journal:  Hum Reprod Update       Date:  2022-02-28       Impact factor: 15.610

Review 8.  High-mobility group box 1 is a driver of inflammation throughout pregnancy.

Authors:  Chelsea A Saito Reis; Justin G Padron; Nainoa D Norman Ing; Claire E Kendal-Wright
Journal:  Am J Reprod Immunol       Date:  2020-09-17       Impact factor: 3.886

Review 9.  Novel pathways of inflammation in human fetal membranes associated with preterm birth and preterm pre-labor rupture of the membranes.

Authors:  Ramkumar Menon; Faranak Behnia; Jossimara Polettini; Lauren S Richardson
Journal:  Semin Immunopathol       Date:  2020-08-12       Impact factor: 11.759

10.  Novel Insights into the Regulatory Role of Nuclear Factor (Erythroid-Derived 2)-Like 2 in Oxidative Stress and Inflammation of Human Fetal Membranes.

Authors:  Ramkumar Menon; Morgan R Peltier
Journal:  Int J Mol Sci       Date:  2020-08-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.